LOS ANGELES, United States: QY Research has recently published a report, titled Global CRISPR And CRISPR-Associated Genes Market Size, Status and Forecast 2020-2026. The research report gives the potential headway openings that prevails in the global market. The report is amalgamated depending on research procured from primary and secondary information. The global CRISPR And CRISPR-Associated Genes market is relied upon to develop generously and succeed in volume and value during the predicted time period. Moreover, the report gives nitty gritty data on different manufacturers, region, and products which are important to totally understanding the market.
Key Companies/Manufacturers operating in the global CRISPR And CRISPR-Associated Genes market include: Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich, Precision Biosciences, Genscript, Sangamo Biosciences Inc., Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, Origene Technologies CRISPR And CRISPR-Associated Genes
Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :
https://www.qyresearch.com/sample-form/form/1941094/global-crispr-and-crispr-associated-genes-market
Segmental Analysis
Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global CRISPR And CRISPR-Associated Genes market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.
Global CRISPR And CRISPR-Associated Genes Market Segment By Type:
CRISPR is a type of gene-editing technology that lets scientists more rapidly and accurately cut and paste genes into DNA. Market Analysis and Insights: Global CRISPR And CRISPR-Associated Genes Market The global CRISPR And CRISPR-Associated Genes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global CRISPR And CRISPR-Associated Genes Scope and Market Size CRISPR And CRISPR-Associated Genes market is segmented 7, and 4. Players, stakeholders, and other participants in the global CRISPR And CRISPR-Associated Genes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast 7 and 4 in terms of revenue and forecast for the period 2015-2026. The following players are covered in this report:Thermo Fisher ScientificEditas MedicineCaribou BiosciencesCRISPR therapeuticsIntellia therapeutics, Inc.CellectisHorizon Discovery PlcSigma AldrichPrecision BiosciencesGenscriptSangamo Biosciences Inc.Lonza Group LimitedIntegrated DNA TechnologiesNew England BiolabsOrigene Technologies CRISPR And CRISPR-Associated Genes
Global CRISPR And CRISPR-Associated Genes Market Segment By Application:
Biotechnology CompaniesPharmaceutical CompaniesAcademic InstitutesResearch and Development Institutes
Competitive Landscape
Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global CRISPR And CRISPR-Associated Genes market.
Key companies operating in the global CRISPR And CRISPR-Associated Genes market include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich, Precision Biosciences, Genscript, Sangamo Biosciences Inc., Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, Origene Technologies CRISPR And CRISPR-Associated Genes
Key questions answered in the report:
For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1941094/global-crispr-and-crispr-associated-genes-market
TOC
1 Report Overview1.1 Study Scope1.2 Key Market Segments1.3 Players Covered: Ranking by CRISPR And CRISPR-Associated Genes Revenue1.4 Market 71.4.1 Global CRISPR And CRISPR-Associated Genes Market Size Growth Rate 7: 2020 VS 20261.4.2 Genome Editing1.4.3 Genetic Engineering1.4.4 GRNA Database/Gene Librar1.4.5 CRISPR Plasmid1.4.6 Human Stem Cells1.4.7 Genetically Modified Organisms/Crops1.4.8 Cell Line Engineering1.5 Market by Application1.5.1 Global CRISPR And CRISPR-Associated Genes Market Share 4: 2020 VS 20261.5.2 Biotechnology Companies1.5.3 Pharmaceutical Companies1.5.4 Academic Institutes1.5.5 Research and Development Institutes1.6 Study Objectives1.7 Years Considered 2 Global Growth Trends2.1 Global CRISPR And CRISPR-Associated Genes Market Perspective (2015-2026)2.2 Global CRISPR And CRISPR-Associated Genes Growth Trends by Regions2.2.1 CRISPR And CRISPR-Associated Genes Market Size by Regions: 2015 VS 2020 VS 20262.2.2 CRISPR And CRISPR-Associated Genes Historic Market Share by Regions (2015-2020)2.2.3 CRISPR And CRISPR-Associated Genes Forecasted Market Size by Regions (2021-2026)2.3 Industry Trends and Growth Strategy2.3.1 Market Top Trends2.3.2 Market Drivers2.3.3 Market Challenges2.3.4 Porters Five Forces Analysis2.3.5 CRISPR And CRISPR-Associated Genes Market Growth Strategy2.3.6 Primary Interviews with Key CRISPR And CRISPR-Associated Genes Players (Opinion Leaders) 3 Competition Landscape by Key Players3.1 Global Top CRISPR And CRISPR-Associated Genes Players by Market Size3.1.1 Global Top CRISPR And CRISPR-Associated Genes Players by Revenue (2015-2020)3.1.2 Global CRISPR And CRISPR-Associated Genes Revenue Market Share by Players (2015-2020)3.1.3 Global CRISPR And CRISPR-Associated Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.2 Global CRISPR And CRISPR-Associated Genes Market Concentration Ratio3.2.1 Global CRISPR And CRISPR-Associated Genes Market Concentration Ratio (CR5 and HHI)3.2.2 Global Top 10 and Top 5 Companies by CRISPR And CRISPR-Associated Genes Revenue in 20193.3 CRISPR And CRISPR-Associated Genes Key Players Head office and Area Served3.4 Key Players CRISPR And CRISPR-Associated Genes Product Solution and Service3.5 Date of Enter into CRISPR And CRISPR-Associated Genes Market3.6 Mergers & Acquisitions, Expansion Plans 4 Market Size 7 (2015-2026)4.1 Global CRISPR And CRISPR-Associated Genes Historic Market Size 7 (2015-2020)4.2 Global CRISPR And CRISPR-Associated Genes Forecasted Market Size 7 (2021-2026) 5 Market Size 4 (2015-2026)5.1 Global CRISPR And CRISPR-Associated Genes Market Size 4 (2015-2020)5.2 Global CRISPR And CRISPR-Associated Genes Forecasted Market Size 4 (2021-2026) 6 North America6.1 North America CRISPR And CRISPR-Associated Genes Market Size (2015-2020)6.2 CRISPR And CRISPR-Associated Genes Key Players in North America (2019-2020)6.3 North America CRISPR And CRISPR-Associated Genes Market Size 7 (2015-2020)6.4 North America CRISPR And CRISPR-Associated Genes Market Size 4 (2015-2020) 7 Europe7.1 Europe CRISPR And CRISPR-Associated Genes Market Size (2015-2020)7.2 CRISPR And CRISPR-Associated Genes Key Players in Europe (2019-2020)7.3 Europe CRISPR And CRISPR-Associated Genes Market Size 7 (2015-2020)7.4 Europe CRISPR And CRISPR-Associated Genes Market Size 4 (2015-2020) 8 China8.1 China CRISPR And CRISPR-Associated Genes Market Size (2015-2020)8.2 CRISPR And CRISPR-Associated Genes Key Players in China (2019-2020)8.3 China CRISPR And CRISPR-Associated Genes Market Size 7 (2015-2020)8.4 China CRISPR And CRISPR-Associated Genes Market Size 4 (2015-2020) 9 Japan9.1 Japan CRISPR And CRISPR-Associated Genes Market Size (2015-2020)9.2 CRISPR And CRISPR-Associated Genes Key Players in Japan (2019-2020)9.3 Japan CRISPR And CRISPR-Associated Genes Market Size 7 (2015-2020)9.4 Japan CRISPR And CRISPR-Associated Genes Market Size 4 (2015-2020) 10 Southeast Asia10.1 Southeast Asia CRISPR And CRISPR-Associated Genes Market Size (2015-2020)10.2 CRISPR And CRISPR-Associated Genes Key Players in Southeast Asia (2019-2020)10.3 Southeast Asia CRISPR And CRISPR-Associated Genes Market Size by Type (2015-2020)10.4 Southeast Asia CRISPR And CRISPR-Associated Genes Market Size by Application (2015-2020) 11 India11.1 India CRISPR And CRISPR-Associated Genes Market Size (2015-2020)11.2 CRISPR And CRISPR-Associated Genes Key Players in India (2019-2020)11.3 India CRISPR And CRISPR-Associated Genes Market Size by Type (2015-2020)11.4 India CRISPR And CRISPR-Associated Genes Market Size by Application (2015-2020) 12 Central & South America12.1 Central & South America CRISPR And CRISPR-Associated Genes Market Size (2015-2020)12.2 CRISPR And CRISPR-Associated Genes Key Players in Central & South America (2019-2020)12.3 Central & South America CRISPR And CRISPR-Associated Genes Market Size by Type (2015-2020)12.4 Central & South America CRISPR And CRISPR-Associated Genes Market Size by Application (2015-2020) 13 Key Players Profiles13.1 Thermo Fisher Scientific13.1.1 Thermo Fisher Scientific Company Details13.1.2 Thermo Fisher Scientific Business Overview13.1.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Introduction13.1.4 Thermo Fisher Scientific Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020))13.1.5 Thermo Fisher Scientific Recent Development13.2 Editas Medicine13.2.1 Editas Medicine Company Details13.2.2 Editas Medicine Business Overview13.2.3 Editas Medicine CRISPR And CRISPR-Associated Genes Introduction13.2.4 Editas Medicine Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020)13.2.5 Editas Medicine Recent Development13.3 Caribou Biosciences13.3.1 Caribou Biosciences Company Details13.3.2 Caribou Biosciences Business Overview13.3.3 Caribou Biosciences CRISPR And CRISPR-Associated Genes Introduction13.3.4 Caribou Biosciences Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020)13.3.5 Caribou Biosciences Recent Development13.4 CRISPR therapeutics13.4.1 CRISPR therapeutics Company Details13.4.2 CRISPR therapeutics Business Overview13.4.3 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Introduction13.4.4 CRISPR therapeutics Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020)13.4.5 CRISPR therapeutics Recent Development13.5 Intellia therapeutics, Inc.13.5.1 Intellia therapeutics, Inc. Company Details13.5.2 Intellia therapeutics, Inc. Business Overview13.5.3 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Introduction13.5.4 Intellia therapeutics, Inc. Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020)13.5.5 Intellia therapeutics, Inc. Recent Development13.6 Cellectis13.6.1 Cellectis Company Details13.6.2 Cellectis Business Overview13.6.3 Cellectis CRISPR And CRISPR-Associated Genes Introduction13.6.4 Cellectis Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020)13.6.5 Cellectis Recent Development13.7 Horizon Discovery Plc13.7.1 Horizon Discovery Plc Company Details13.7.2 Horizon Discovery Plc Business Overview13.7.3 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Introduction13.7.4 Horizon Discovery Plc Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020)13.7.5 Horizon Discovery Plc Recent Development13.8 Sigma Aldrich13.8.1 Sigma Aldrich Company Details13.8.2 Sigma Aldrich Business Overview13.8.3 Sigma Aldrich CRISPR And CRISPR-Associated Genes Introduction13.8.4 Sigma Aldrich Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020)13.8.5 Sigma Aldrich Recent Development13.9 Precision Biosciences13.9.1 Precision Biosciences Company Details13.9.2 Precision Biosciences Business Overview13.9.3 Precision Biosciences CRISPR And CRISPR-Associated Genes Introduction13.9.4 Precision Biosciences Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020)13.9.5 Precision Biosciences Recent Development13.10 Genscript13.10.1 Genscript Company Details13.10.2 Genscript Business Overview13.10.3 Genscript CRISPR And CRISPR-Associated Genes Introduction13.10.4 Genscript Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020)13.10.5 Genscript Recent Development13.11 Sangamo Biosciences Inc.10.11.1 Sangamo Biosciences Inc. Company Details10.11.2 Sangamo Biosciences Inc. Business Overview10.11.3 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Introduction10.11.4 Sangamo Biosciences Inc. Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020)10.11.5 Sangamo Biosciences Inc. Recent Development13.12 Lonza Group Limited10.12.1 Lonza Group Limited Company Details10.12.2 Lonza Group Limited Business Overview10.12.3 Lonza Group Limited CRISPR And CRISPR-Associated Genes Introduction10.12.4 Lonza Group Limited Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020)10.12.5 Lonza Group Limited Recent Development13.13 Integrated DNA Technologies10.13.1 Integrated DNA Technologies Company Details10.13.2 Integrated DNA Technologies Business Overview10.13.3 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Introduction10.13.4 Integrated DNA Technologies Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020)10.13.5 Integrated DNA Technologies Recent Development13.14 New England Biolabs10.14.1 New England Biolabs Company Details10.14.2 New England Biolabs Business Overview10.14.3 New England Biolabs CRISPR And CRISPR-Associated Genes Introduction10.14.4 New England Biolabs Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020)10.14.5 New England Biolabs Recent Development13.15 Origene Technologies10.15.1 Origene Technologies Company Details10.15.2 Origene Technologies Business Overview10.15.3 Origene Technologies CRISPR And CRISPR-Associated Genes Introduction10.15.4 Origene Technologies Revenue in CRISPR And CRISPR-Associated Genes Business (2015-2020)10.15.5 Origene Technologies Recent Development 14 Analysts Viewpoints/Conclusions 15 Appendix15.1 Research Methodology15.1.1 Methodology/Research Approach15.1.2 Data Source15.2 Disclaimer15.3 Author Details
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
See the original post:
- IOM not webcast today. Why Not? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- National Academies skeptical at Best. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Some Confusion Exists [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Why DTC Genomics IS Medicine. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- First Mari, Now Linda. Who's next? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Is it true? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Re-Reviewing the National Academies [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- The problem with nonclinicians....... [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Crazy Night of Emails to Government [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Adrienne Carlson's Personalized Medicine. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Tell Me, How do you feel now? Sherpa's RX [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- This Just In. 23andMe to go to GPs. I love my readers!! [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Sorry so long away [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- 2D6 Rears its ugly head..... [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Ok, Fine, Back to Plavix [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Kaiser a protoype for Collins' Aim [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- A few months late to the party.... [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Stated Another Way....... [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Excuse Me? Harvard and Navigenics? WTF? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Follow up to Yesterday's WTF? Harvard, Navi? and Pfizer??? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Did you get your kit? Thanks Dr. Rob from MedCo [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Gluco...Wha? Parkinson's Disease and Glucocerebrosidase mutations. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Away and now back, What did I miss???? 23andme layoffs? Selling Genomes for cheap up next! [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Change IS Needed. I agree with William, sometimes. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Good Enough Science? Apparently so at 23andme [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Long QT Syndrome, location matters [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- Congratulations Generation Health. Nice pick up! [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- An argument 23andSerge can't win...23andme but not medicine [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- Stop. Breathe. Repeat. An analysis of the direction of DTC Genomics Field. [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- Hey DTC genomics, Stay Private, Stay Alive, Go Public and Die [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- You can't have it both way. Either scared your genome is sold off or not. [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- 15 Days Away Gives Time for Perspective. [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- What about the SACGHS registry? Another missed opportunity? [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- AJHG is in and my Favorite Muin is in it! But He Is NOT the Father! [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- Navigenics for 23andMe prices? [Last Updated On: December 18th, 2009] [Originally Added On: December 18th, 2009]
- Lp(a) Maybe there's something there that wasn't there before? [Last Updated On: December 24th, 2009] [Originally Added On: December 24th, 2009]
- Another Year, Another Bankruptcy [Last Updated On: December 31st, 2009] [Originally Added On: December 31st, 2009]
- 5 Technologies going bye bye in this decade? [Last Updated On: January 6th, 2010] [Originally Added On: January 6th, 2010]
- Hackers, HITECH and HIPAA in DTC Genomics, Oh My! [Last Updated On: January 7th, 2010] [Originally Added On: January 7th, 2010]
- Personal Genomics Flop.....big Belly Flop! [Last Updated On: January 8th, 2010] [Originally Added On: January 8th, 2010]
- Gotta Love It. Even the daycare....... [Last Updated On: January 11th, 2010] [Originally Added On: January 11th, 2010]
- Congratulations Navigenics. You ARE a clinical lab! Uh-Oh... [Last Updated On: January 12th, 2010] [Originally Added On: January 12th, 2010]
- CETP, Jewish Centenarians and Alzheimers [Last Updated On: January 14th, 2010] [Originally Added On: January 14th, 2010]
- Enter the "Not" DTC Genomics Rep [Last Updated On: January 17th, 2010] [Originally Added On: January 17th, 2010]
- Why Dr. Vanier's Navigenics appointment is good for PM [Last Updated On: January 22nd, 2010] [Originally Added On: January 22nd, 2010]
- Holy Crap! MedCo Follows in CVS footsteps [Last Updated On: February 3rd, 2010] [Originally Added On: February 3rd, 2010]
- FDA, Warfarin, still not as sexy to me. [Last Updated On: February 5th, 2010] [Originally Added On: February 5th, 2010]
- Hype, Hype, Hype from a single study. [Last Updated On: February 11th, 2010] [Originally Added On: February 11th, 2010]
- I love my readers, even Renata M! [Last Updated On: February 17th, 2010] [Originally Added On: February 17th, 2010]
- How can insurers use DTC genomics to profile? [Last Updated On: February 17th, 2010] [Originally Added On: February 17th, 2010]
- 9p21.....ahem. Paynter et.al. Smackdown. Again. [Last Updated On: February 18th, 2010] [Originally Added On: February 18th, 2010]
- Hey! It's Pete Hulick! Are you Going to GET? [Last Updated On: February 19th, 2010] [Originally Added On: February 19th, 2010]
- I was wrong......AHEM [Last Updated On: February 28th, 2010] [Originally Added On: February 28th, 2010]
- G2C2, finally a tool for genomic education! [Last Updated On: March 2nd, 2010] [Originally Added On: March 2nd, 2010]
- Just 4 million? What 23andMe is worth. [Last Updated On: March 5th, 2010] [Originally Added On: March 5th, 2010]
- What a difference a year makes [Last Updated On: March 9th, 2010] [Originally Added On: March 9th, 2010]
- ........DTC Genomic Medicine? [Last Updated On: March 12th, 2010] [Originally Added On: March 12th, 2010]
- The FDA, 2c19 and the ACC [Last Updated On: March 13th, 2010] [Originally Added On: March 13th, 2010]
- The problem with Comparative Whole Genomics...... [Last Updated On: March 13th, 2010] [Originally Added On: March 13th, 2010]
- BRCA testing by 23andME is the same as Myriad Genetics. [Last Updated On: March 15th, 2010] [Originally Added On: March 15th, 2010]
- The Argument Against DTC Genomics Marketing and such [Last Updated On: March 16th, 2010] [Originally Added On: March 16th, 2010]
- A moment of Clarity. Some DTCG is not bad. [Last Updated On: March 18th, 2010] [Originally Added On: March 18th, 2010]
- SNPs for breast cancer risk? It Depends. [Last Updated On: March 18th, 2010] [Originally Added On: March 18th, 2010]
- How can MDVIP use Navigenics Test for Medicine? [Last Updated On: March 18th, 2010] [Originally Added On: March 18th, 2010]
- Why did P&G invest in Navigenics? [Last Updated On: March 23rd, 2010] [Originally Added On: March 23rd, 2010]
- PGx in DTCG? Doesn't stand up to Useful testing. [Last Updated On: March 25th, 2010] [Originally Added On: March 25th, 2010]
- End of Gene Patents? [Last Updated On: March 29th, 2010] [Originally Added On: March 29th, 2010]
- Sherpa Accepting Chief Medical Officership [Last Updated On: April 3rd, 2010] [Originally Added On: April 3rd, 2010]
- The Rumors of My Death........ [Last Updated On: April 20th, 2010] [Originally Added On: April 20th, 2010]
- Happy DNA Day! [Last Updated On: April 25th, 2010] [Originally Added On: April 25th, 2010]
- 99 USD, DNA day and patient letters [Last Updated On: April 25th, 2010] [Originally Added On: April 25th, 2010]
- 2C19, Navigenics and Clinical Reality. [Last Updated On: May 1st, 2010] [Originally Added On: May 1st, 2010]
- Coriell Personalized Medicine Collaborative rising [Last Updated On: May 7th, 2010] [Originally Added On: May 7th, 2010]
- Personal Genomes in Clinical Care. Quake paper is a waste! [Last Updated On: May 11th, 2010] [Originally Added On: May 11th, 2010]
- Personal Genomes in Clinical Care. Quake paper Falls Short! [Last Updated On: May 13th, 2010] [Originally Added On: May 13th, 2010]
- Last post edited by Drew [Last Updated On: May 13th, 2010] [Originally Added On: May 13th, 2010]
- GateKeeper? FCUK U! [Last Updated On: May 13th, 2010] [Originally Added On: May 13th, 2010]
- GateKeeper? F! U! [Last Updated On: May 15th, 2010] [Originally Added On: May 15th, 2010]
- Potential of genomic medicine, LOST [Last Updated On: May 19th, 2010] [Originally Added On: May 19th, 2010]
- How Bad Can a House Investigation be for DTC Genomics? [Last Updated On: May 20th, 2010] [Originally Added On: May 20th, 2010]